ENDRA Life Sciences (NASDAQ:NDRA) Releases Earnings Results, Misses Expectations By $2.02 EPS

ENDRA Life Sciences (NASDAQ:NDRA) released its quarterly earnings data on Tuesday. The company reported ($3.25) EPS for the quarter, missing the consensus estimate of ($1.23) by ($2.02), FiscalAI reports.

ENDRA Life Sciences Trading Down 0.6%

Shares of NDRA stock traded down $0.03 during trading hours on Tuesday, reaching $4.65. The stock had a trading volume of 15,329 shares, compared to its average volume of 71,223. The stock’s fifty day simple moving average is $3.80 and its 200 day simple moving average is $4.86. The firm has a market capitalization of $3.49 million, a PE ratio of -0.18 and a beta of -0.08. ENDRA Life Sciences has a 12 month low of $2.90 and a 12 month high of $11.96.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on NDRA shares. Ascendiant Capital Markets lowered their target price on shares of ENDRA Life Sciences from $38.00 to $30.00 and set a “buy” rating on the stock in a report on Monday, December 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of ENDRA Life Sciences in a report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $30.00.

About ENDRA Life Sciences

ENDRA Life Sciences, Inc (NASDAQ: NDRA) is a medical technology company headquartered in Ann Arbor, Michigan, that focuses on the development and commercialization of Thermoacoustic Enhanced Ultrasound (TAEUS™) imaging. The company’s proprietary TAEUS platform combines conventional ultrasound with thermoacoustic signals to provide non-invasive, real-time temperature monitoring of soft tissue. This technology is designed to improve the safety, efficacy and outcomes of thermal ablation procedures and other heat-based therapies.

ENDRA’s core product line centers on a compact, easy-to-integrate device that augments existing ultrasound systems.